Aristo Bio-Tech And Lifescience Limited
ARISTO (NSE) · ISIN INE082101010 · Pesticides & Agrochemicals · listed 2023
Not on any surveillance list
In Q2 FY25 (quarter to 30 September 2024, standalone), revenue was ₹214.15 cr and profit after tax ₹4.55 cr.
Open the full company file Every section, filings and your notes, in the app.
Quarterly results
| Quarter | Revenue | Profit after tax | EPS (₹) | Filed |
|---|---|---|---|---|
| Q2 FY25 standalone | ₹214.15 cr | ₹4.55 cr | 6.69 | 15 Nov 2024 |
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹44.51 cr | ₹35.4 cr | ₹155.22 cr |
| 30 Sep 2025 standalone | ₹41.5 cr | ₹34.68 cr | ₹250.11 cr |
| 31 Mar 2025 standalone | ₹37.33 cr | ₹21.85 cr | ₹140.62 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 73.42% | 0.00% | 0.00% | 26.58% |
Latest filings
- Annual Report FY2025-26 (New) 8 September 2026 · NSE
- Aristo Bio-Tech And Lifescience Limited has informed the Exchange regarding Outcome of Board Meeting held on September 07, 2026. 7 September 2026 · NSE
- Aristo Bio-Tech And Lifescience Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. 30 May 2026 · NSE
- Submission of Structural Digital Database Compliance Certificate under SEBI (Prohibition of Insider Trading) Regulations, 2015, for the year ended 31st March, 2026 28 May 2026 · NSE
- Narendra Singh Barhat has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulati 25 May 2026 · NSE
Other companies in Pesticides & Agrochemicals
- UPL Limited
- PI Industries Limited
- Sharda Cropchem Limited
- Sumitomo Chemical India Limited
- Rallis India Limited
- Insecticides (India) Limited
- Meghmani Organics Limited
- Dhanuka Agritech Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.